Mara Graziani, Greta Barbieri, Giorgio Maraziti, Marco Falcone, Anna Fiaccadori, Francesco Corradi, Lorenzo Ghiadoni, Katarzyna Satula, Ghislaine Noumi, Cecilia Becattini
{"title":"俯卧位在非重症监护病房sars - cov -2相关呼吸衰竭患者中的作用","authors":"Mara Graziani, Greta Barbieri, Giorgio Maraziti, Marco Falcone, Anna Fiaccadori, Francesco Corradi, Lorenzo Ghiadoni, Katarzyna Satula, Ghislaine Noumi, Cecilia Becattini","doi":"10.1177/17534666231164536","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Prone positioning (PP) is an established and commonly used lung recruitment method for intubated patients with severe acute respiratory distress syndrome, with potential benefits in clinical outcome. The role of PP outside the intensive care unit (ICU) setting is debated.</p><p><strong>Objectives: </strong>We aimed at assessing the role of PP in death and ICU admission in non-intubated patients with acute respiratory failure related to COronaVIrus Disease-19 (COVID-19) pneumonia.</p><p><strong>Design: </strong>This is a retrospective analysis of a collaborative multicenter database obtained by merging local non-interventional cohorts.</p><p><strong>Methods: </strong>Consecutive adult patients with COVID-19-related respiratory failure were included in a collaborative cohort and classified based on the severity of respiratory failure according to the partial arterial oxygen pressure to fraction of inspired oxygen ratio (PaO<sub>2</sub>/FiO<sub>2</sub>) and on clinical severity by the quick Sequential Organ Failure Assessment (qSOFA) score. The primary study outcome was the composite of in-hospital death or ICU admission within 30 days from hospitalization.</p><p><strong>Results: </strong>PP was used in 114 of 536 study patients (21.8%), more commonly in patients with lower PaO<sub>2</sub>/FiO<sub>2</sub> or receiving non-invasive ventilation and less commonly in patients with known comorbidities. A primary study outcome event occurred in 163 patients (30.4%) and in-hospital death in 129 (24.1%). PP was not associated with death or ICU admission (HR 1.17, 95% CI 0.78-1.74) and not with death (HR 1.01, 95% CI 0.61-1.67) at multivariable analysis; PP was an independent predictor of ICU admission (HR 2.64, 95% CI 1.53-4.40). The lack of association between PP and death or ICU admission was confirmed at propensity score-matching analysis.</p><p><strong>Conclusion: </strong>PP is used in a non-negligible proportion of non-intubated patients with COVID-19-related severe respiratory failure and is not associated with death but with ICU admission. The role of PP in this setting merits further evaluation in randomized studies.</p>","PeriodicalId":22884,"journal":{"name":"Therapeutic Advances in Respiratory Disease","volume":"17 ","pages":"17534666231164536"},"PeriodicalIF":3.3000,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/af/e8/10.1177_17534666231164536.PMC10140778.pdf","citationCount":"2","resultStr":"{\"title\":\"The role of prone positioning in patients with SARS-CoV-2-related respiratory failure in non-intensive care unit.\",\"authors\":\"Mara Graziani, Greta Barbieri, Giorgio Maraziti, Marco Falcone, Anna Fiaccadori, Francesco Corradi, Lorenzo Ghiadoni, Katarzyna Satula, Ghislaine Noumi, Cecilia Becattini\",\"doi\":\"10.1177/17534666231164536\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>Prone positioning (PP) is an established and commonly used lung recruitment method for intubated patients with severe acute respiratory distress syndrome, with potential benefits in clinical outcome. The role of PP outside the intensive care unit (ICU) setting is debated.</p><p><strong>Objectives: </strong>We aimed at assessing the role of PP in death and ICU admission in non-intubated patients with acute respiratory failure related to COronaVIrus Disease-19 (COVID-19) pneumonia.</p><p><strong>Design: </strong>This is a retrospective analysis of a collaborative multicenter database obtained by merging local non-interventional cohorts.</p><p><strong>Methods: </strong>Consecutive adult patients with COVID-19-related respiratory failure were included in a collaborative cohort and classified based on the severity of respiratory failure according to the partial arterial oxygen pressure to fraction of inspired oxygen ratio (PaO<sub>2</sub>/FiO<sub>2</sub>) and on clinical severity by the quick Sequential Organ Failure Assessment (qSOFA) score. The primary study outcome was the composite of in-hospital death or ICU admission within 30 days from hospitalization.</p><p><strong>Results: </strong>PP was used in 114 of 536 study patients (21.8%), more commonly in patients with lower PaO<sub>2</sub>/FiO<sub>2</sub> or receiving non-invasive ventilation and less commonly in patients with known comorbidities. A primary study outcome event occurred in 163 patients (30.4%) and in-hospital death in 129 (24.1%). PP was not associated with death or ICU admission (HR 1.17, 95% CI 0.78-1.74) and not with death (HR 1.01, 95% CI 0.61-1.67) at multivariable analysis; PP was an independent predictor of ICU admission (HR 2.64, 95% CI 1.53-4.40). The lack of association between PP and death or ICU admission was confirmed at propensity score-matching analysis.</p><p><strong>Conclusion: </strong>PP is used in a non-negligible proportion of non-intubated patients with COVID-19-related severe respiratory failure and is not associated with death but with ICU admission. The role of PP in this setting merits further evaluation in randomized studies.</p>\",\"PeriodicalId\":22884,\"journal\":{\"name\":\"Therapeutic Advances in Respiratory Disease\",\"volume\":\"17 \",\"pages\":\"17534666231164536\"},\"PeriodicalIF\":3.3000,\"publicationDate\":\"2023-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/af/e8/10.1177_17534666231164536.PMC10140778.pdf\",\"citationCount\":\"2\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Therapeutic Advances in Respiratory Disease\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1177/17534666231164536\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"RESPIRATORY SYSTEM\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Therapeutic Advances in Respiratory Disease","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1177/17534666231164536","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"RESPIRATORY SYSTEM","Score":null,"Total":0}
引用次数: 2
摘要
背景:俯卧位(俯卧位)是重度急性呼吸窘迫综合征插管患者常用的肺补充方法,在临床预后方面具有潜在的益处。PP在重症监护病房(ICU)外的作用是有争议的。目的:我们旨在评估PP在冠状病毒病-19 (COVID-19)肺炎相关急性呼吸衰竭非插管患者死亡和ICU入住中的作用。设计:这是对合并当地非介入队列获得的协作多中心数据库的回顾性分析。方法:将连续发生covid -19相关呼吸衰竭的成人患者纳入合作队列,根据部分动脉氧压与吸入氧分数(PaO2/FiO2)和快速顺序器官衰竭评估(qSOFA)评分对呼吸衰竭严重程度进行分类。主要研究结果为住院后30天内住院死亡或ICU入院。结果:536例患者中有114例(21.8%)使用了PP,更常见于PaO2/FiO2较低或接受无创通气的患者,较少见于已知合并症的患者。163例(30.4%)患者发生主要研究结果事件,129例(24.1%)患者住院死亡。在多变量分析中,PP与死亡或ICU入院无关(HR 1.17, 95% CI 0.78-1.74),与死亡无关(HR 1.01, 95% CI 0.61-1.67);PP是ICU入院的独立预测因子(HR 2.64, 95% CI 1.53-4.40)。倾向评分匹配分析证实了PP与死亡或ICU入院之间缺乏关联。结论:PP在非插管的covid -19相关严重呼吸衰竭患者中占不可忽略的比例,与死亡无关,但与ICU住院有关。在这种情况下,PP的作用值得在随机研究中进一步评估。
The role of prone positioning in patients with SARS-CoV-2-related respiratory failure in non-intensive care unit.
Background: Prone positioning (PP) is an established and commonly used lung recruitment method for intubated patients with severe acute respiratory distress syndrome, with potential benefits in clinical outcome. The role of PP outside the intensive care unit (ICU) setting is debated.
Objectives: We aimed at assessing the role of PP in death and ICU admission in non-intubated patients with acute respiratory failure related to COronaVIrus Disease-19 (COVID-19) pneumonia.
Design: This is a retrospective analysis of a collaborative multicenter database obtained by merging local non-interventional cohorts.
Methods: Consecutive adult patients with COVID-19-related respiratory failure were included in a collaborative cohort and classified based on the severity of respiratory failure according to the partial arterial oxygen pressure to fraction of inspired oxygen ratio (PaO2/FiO2) and on clinical severity by the quick Sequential Organ Failure Assessment (qSOFA) score. The primary study outcome was the composite of in-hospital death or ICU admission within 30 days from hospitalization.
Results: PP was used in 114 of 536 study patients (21.8%), more commonly in patients with lower PaO2/FiO2 or receiving non-invasive ventilation and less commonly in patients with known comorbidities. A primary study outcome event occurred in 163 patients (30.4%) and in-hospital death in 129 (24.1%). PP was not associated with death or ICU admission (HR 1.17, 95% CI 0.78-1.74) and not with death (HR 1.01, 95% CI 0.61-1.67) at multivariable analysis; PP was an independent predictor of ICU admission (HR 2.64, 95% CI 1.53-4.40). The lack of association between PP and death or ICU admission was confirmed at propensity score-matching analysis.
Conclusion: PP is used in a non-negligible proportion of non-intubated patients with COVID-19-related severe respiratory failure and is not associated with death but with ICU admission. The role of PP in this setting merits further evaluation in randomized studies.
期刊介绍:
Therapeutic Advances in Respiratory Disease delivers the highest quality peer-reviewed articles, reviews, and scholarly comment on pioneering efforts and innovative studies across all areas of respiratory disease.